Cargando…

Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat

Despite prominent role of radiotherapy in lung cancer management, there is an urgent need for strategies increasing therapeutic efficacy. Reversible epigenetic changes are promising targets for combination strategies using HDAC inhibitors (HDACi). Here we evaluated on two NSCLC cell lines, the antit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivera, Sofia, Leteur, Céline, Mégnin, Frédérique, Law, Frédéric, Martins, Isabelle, Kloos, Ioana, Depil, Stéphane, Modjtahedi, Nazanine, Perfettini, Jean Luc, Hennequin, Christophe, Deutsch, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593556/ https://www.ncbi.nlm.nih.gov/pubmed/28915585 http://dx.doi.org/10.18632/oncotarget.14813

Ejemplares similares

Macrophage biology plays a central role during ionizing radiation-elicited tumor response
por: Wu, Qiuji, et al.
Publicado: (2017)

A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors
por: Deutsch, Eric, et al.
Publicado: (2016)

Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness
por: Wu, Qiuji, et al.
Publicado: (2017)

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
por: Ribrag, Vincent, et al.
Publicado: (2017)

Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms
por: Ali, A, et al.
Publicado: (2013)

Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts
por: Gressette, Mélanie, et al.
Publicado: (2014)

Radiosensitization by a novel Bcl-2 and Bcl-X(L) inhibitor S44563 in small-cell lung cancer
por: Loriot, Y, et al.
Publicado: (2014)

Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay
por: Arena, Giuseppe, et al.
Publicado: (2021)

The Mia40/CHCHD4 Oxidative Folding System: Redox Regulation and Signaling in the Mitochondrial Intermembrane Space
por: Dickson-Murray, Eleanor, et al.
Publicado: (2021)

Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death
por: Martins, Isabelle, et al.
Publicado: (2018)

Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation
por: Silina, Linda, et al.
Publicado: (2022)

HDAC inhibitor confers radiosensitivity to prostate stem-like cells
por: Frame, F M, et al.
Publicado: (2013)

MMP14 Contributes to HDAC Inhibition-Induced Radiosensitization of Glioblastoma
por: Zhou, Yuchuan, et al.
Publicado: (2021)

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
por: Ko, A, et al.
Publicado: (2014)

Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2022)

Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells
por: Moertl, Simone, et al.
Publicado: (2019)

Characterizing HDAC Pathway Copy Number Variation in Pan-Cancer
por: Yang, Shuming, et al.
Publicado: (2022)

Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors
por: Laurent, Pierre-Antoine, et al.
Publicado: (2022)

HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
por: Moses, Niko, et al.
Publicado: (2020)

Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
por: Fukumoto, Takeshi, et al.
Publicado: (2018)

Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
por: Jeong, Hyeanjeong, et al.
Publicado: (2019)

The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distribution
por: Mégnin-Chanet, Frédérique, et al.
Publicado: (2002)

Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma
por: Liu, Yu-Fan, et al.
Publicado: (2022)

Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling
por: Tsai, Yu-Chieh, et al.
Publicado: (2023)

Targeting poly(ADP-ribose) polymerase activity for cancer therapy
por: Mégnin-Chanet, Frédérique, et al.
Publicado: (2010)

Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat
por: Afolabi, Lukman O., et al.
Publicado: (2021)

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial
por: Bourgier, Céline, et al.
Publicado: (2018)

Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line
por: Kusaczuk, Magdalena, et al.
Publicado: (2015)

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
por: Bandolik, Jan J., et al.
Publicado: (2019)

Entosis: The emerging face of non-cell-autonomous type IV programmed death [Image: see text]
por: Martins, Isabelle, et al.
Publicado: (2017)

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
por: Zhu, Yuxuan, et al.
Publicado: (2019)

Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine deprivation
por: Nedara, Kenza, et al.
Publicado: (2022)

Poly(ADP-ribose) polymerase (PARP-1) is not involved in DNA double-strand break recovery
por: Noël, Georges, et al.
Publicado: (2003)

Cancer vaccines: what’s next?
por: Depil, Stéphane, et al.
Publicado: (2019)

Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers
por: Alcazer, Vincent, et al.
Publicado: (2020)

Apoptosis inducing factor (AIF) mediates lethal redox stress induced by menadione
por: Wiraswati, Hesti Lina, et al.
Publicado: (2016)

Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
por: Venturelli, Sascha, et al.
Publicado: (2013)

Aggresome–Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma
por: Zhang, Zhiyong, et al.
Publicado: (2021)

DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2022)

Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells
por: Tsai, Feng-Lung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6ujpusjmb7nt97telaeacmu5v2